Kim Blackwell, incoming CEO, Zentalis Pharmaceuticals
May 16, 2022 11:36 AM EDTUpdated May 17, 11:48 AM
People
Financing

Pfiz­er-part­nered Zen­tal­is woos new CEO, cob­bles to­geth­er $200M

Amber Tong

Ready to trans­form it­self in­to a se­ri­ous mid- to late-stage can­cer play­er that could take on ri­vals as big as As­traZeneca, a Pfiz­er-part­nered biotech is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times